Document is current

Article History

Received: 30 July 2024

Accepted: 21 October 2024

First Online: 2 December 2024

Declarations

:

: P. Calzavara-Pinton is an advisory board member for AbbVie, Almirall, Galderma, LEO Pharma, Meda, and Sanofi. C-Y. Chu is an investigator for AbbVie, Dermira, Eli Lilly, Novartis, Oneness Biotech, Pfizer, Regeneron Pharmaceuticals Inc., Roche, and Sanofi; a consultant for AbbVie, Eli Lilly, Novartis, Pfizer, Roche, and Sanofi; a speaker for AbbVie, Eli Lilly, Mylan, Novartis, Pfizer, Roche, Sanofi, and Viatris; and an advisory board member for Mylan, Pfizer, Roche, and Sanofi. Hilde Lapeere is on the advisory boards of AbbVie, LEO Pharma, Eli Lilly, Pfizer, and Sanofi. M. Rossi is a speaker for AbbVie, Galderma, La Roche-Posay, LEO Pharma, Pfizer, and Sanofi. S.M. Ferrucci is an advisory board member for AbbVie, Eli Lilly, and Sanofi; a principal Investigator for Almirall, Menarini, and Pfizer; and reports honoraria for lectures and research grants from Novartis. W-H. Chung has nothing to disclose. A-C. Fougerousse is a consultant for AbbVie, Galderma, LEO Pharma, Lilly, and Sanofi; and a consultant for AbbVie, Eli Lilly, and Sanofi. D.S. Fomina reports honoraria from CSL Behring, Novartis, Sanofi, and Shire. G. Holzer is an advisory board member for AbbVie, Almirall, Eli Lilly, Galderma, LEO Pharma, and Sanofi. J. Čelakovská has nothing to disclose. M. Al-Ahmad is an advisory board member and speaker for AstraZeneca, GSK, and Novartis. T. Tzellos has received honoraria from and is an advisory board member and speaker for AbbVie; and has received honoraria from and is an advisory board member for Boehringer Ingelheim and Sanofi. J. Wu is an employee of Sanofi, and may hold stock and/or stock options in the company. M. Ardeleanu is an employee and shareholder of Regeneron Pharmaceuticals Inc. K. Bosman is an employee and shareholder of Sanofi.

: The study was conducted in accordance with the Declaration of Helsinki, the International Conference on Harmonisation Good Clinical Practice guideline and applicable regulatory requirements. The local institutional review board or ethics committee at each study center oversaw trial conduct and documentation. All patients, or their parents/guardians, provided written informed consent before participating in the trial. Pediatric patients provided assent according to the ethics committee (institutional review board/independent ethics committee)-approved standard practice for pediatric patients at each participating center.